In addition to BRCA1 and BRCA2, we were also interested in evaluating the expression of poly(ADP-ribose) polymerase (PARP) genes, representing another key gene family in BC and OV pathophysiology and treatment [38,39,40]. The gene discussed is PARP1; the disease is breast cancer.